|
|
 |
Oncotype DX | | | General Information | |
| Vendor | | Genomic Health, Inc. | | Item | | Oncotype DX | | Features | | - It is sensitive, specific, highly reproducible, and has a wide dynamic range.
- RT-PCR is a mature technology that is routinely utilized in several clinical applications including viral load testing for HIV.
| | Approval | | Pending | | Product Number | | Inquire | | Analysis Time | | The Oncotype DX assay report is sent by fax, overnight mail, or secure online transfer to the treating physicians and submitting pathologist. | | Sensitivity | | Inquire | | Instrumentation Needed | | Inquire | | Test Method | | Real-time RT-PCR | | Number of Tests | | Inquire | | Pricing |  | Inquire | | Financing | | To finance this purchase click here (U.S. customers only) |
| | Product Description | |
| Oncotype DX™ is a diagnostic assay that quantifies the likelihood of breast cancer recurrence in women with newly diagnosed, early stage breast cancer. In addition to predicting distant disease recurrence, Oncotype DX also assesses the benefit from certain types of chemotherapy. The assay — performed using formalin-fixed, paraffin-embedded tumor tissue — analyzes the expression of a panel of 21 genes and the results are provided as a Recurrence Score™ (0-100). The gene panel was selected and the Recurrence Score calculation was derived through extensive laboratory testing and multiple independent clinical development studies. | |
| Genomic Health, Inc. | | Customer Service: (866) 662-6897 | | Web site: http://www.genomichealth.com/ | | Please mention Medcompare.com when you contact the vendor. |
| NOTE: Medcompare disclaims any information on this site. The information found on Medcompare (Drug Guide, Product Listings and otherwise) is intended for use by medical professionals. This information is not intended to replace the information, advice or instructions from a medical doctor. Pricing information is approximate, actual prices may vary. |
|
|
